Patients with bladder cancer have a substantially increased risk of prostate cancer, compared with that of the general male population, and a diagnosis of concomitant prostate cancer can contribute to inferior outcomes, particularly in patients with muscle-invasive bladder cancer. Here, the authors describe the outcomes of such patients, in addition to the optimal treatment and management strategies and future research needs.
- Antonio Lopez-Beltran
- Liang Cheng
- Rodolfo Montironi
